KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment.
<h4>Background</h4>Monoclonal antibodies directed against the epidermal growth factor receptor (EGFR) have been approved for the treatment of patients with metastatic colorectal carcinoma (mCRC) that do not carry KRAS mutations. Therefore, KRAS testing has become mandatory to chose the m...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Public Library of Science (PLoS)
2011
|
| Subjects: | |
| Online Access: | https://doaj.org/article/87fffbc73bfa46eb9c3567483e04245e |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!